Previous Page  9 / 22 Next Page
Information
Show Menu
Previous Page 9 / 22 Next Page
Page Background

Page 42

S e p t e m b e r 0 6 - 0 7 , 2 0 1 8 | B a n g k o k , T h a i l a n d

allied

academies

Joint Event on

Global Women Health 2018 & Orthopedics Congress 2018

Archives of General Internal Medicine

|

ISSN: 2591-7951

|

Volume 2

BREAST CANCER, GYNECOLOGY AND WOMEN HEALTH

ORTHOPEDICS AND RHEUMATOLOGY

&

World Congress on

Annual Conference on

Arch Gen Intern Med 2018, Volume 2 | DOI: 10.4066/2591-7951-C3-009

ELECTRICAL INHIBITION (EI) OF PRETERM UTERINE ELECTRICAL AND

MECHANICAL ACTIVITY

Jeffrey Karsdon

1

, Kathryn E Patrick

1

, Frederick Naftolin

2

, Neil Euliano

3

and

Anthony Gregg

1

1

University of Florida, USA

2

New York University Medical Center, USA

3

O B Medical, Gainesville, USA

Introduction:

Uterine smooth muscle electrical activity precedes mechanical contractions and can be monitored with uterine

electromyogram (EMG). A novel localized electrical method is proposed, electrical inhibition (EI), that uses a weak electrical current

as a theorized uterine pacemaker to alter preterm activity of the uterus. The effect of EI on uterine activity can be objectively

monitored using uterine tocodynamometry (TOCO) and EMG. The investigators hypothesis, preterm uterine electrical and

mechanical activity can be inhibited by EI.

Methods:

Patients in preterm labor between 24-34 weeks gestation were identified and consented as per an IRB-approved protocol.

An FDA-approved EI catheter was placed into the vagina adjacent to the posterior cervix under ultrasound guidance. Each patient

underwent a 20-minute pre-EI (C1) period, a 20-minute EI intervention (EI) period, and a 20-minute post-EI control (C2) period. EI

was administered by the FDA-approved EI device. During the EI intervention, a constant bipolar current (0-20 mA at 0-50 Hz) was

manually administered for 10 s with a pulse duration of 0-20 ms at the time of a contraction based on EMG recording. Uterine

EMG was recorded with abdominal surface electrodes. The uterine EMG was computerized to produce the electro-hysterogram

(EHG) and EMG power spectral density (PSD). TOCO and EHG contraction frequency or peak-to-peak (P-P) interval and EMG peak

frequency (Pf) were calculated from the PSD. A paired student t-test was used to analyze differences in P-P and Pf between each

C1, EI, and C2 periods at the 0.05 significance level.

Results:

The average Pf was significantly decreased between CI and EI intervention periods (0.306 vs. 0.221 Hz, p=0.045) as well

as between C1 and C2 periods (0.306 vs. 0.202 Hz, p=0.022). The average P-P interval was significantly increased between C1 and

EI periods (7.1 vs. 11 min, p=0.047). Finally, uterine contraction frequency on TOCO was decreased between C2 and C1 periods (5.5

vs. 8.3 min). There were no adverse events in either mother-neonate dyad related to EI intervention.

Conclusion:

Preterm human uterine electrical and mechanical activity were decreased with EI. Knowledge from this study could

advance the field of preterm birth prevention by supporting the development of an electroceutical tocolytic that obviates the

systemic maternofetal side effects of traditional tocolytics.